{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:13:06Z","timestamp":1781280786941,"version":"3.54.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01461-3","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:26:45Z","timestamp":1760423205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolving Treatment Paradigms of Meningiomas; a Precision Medicine Perspective"],"prefix":"10.1007","volume":"25","author":[{"given":"Daniela","family":"Galluzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casandra","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Alok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia C.","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"12 Suppl 2","key":"1461_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2016\u20132020. Neuro Oncol. 2023;25(12 Suppl 2):iv1\u201399. https:\/\/doi.org\/10.1093\/neuonc\/noad149.","journal-title":"Neuro Oncol"},{"issue":"Suppl 1","key":"1461_CR2","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/noajnl\/vdad020","volume":"5","author":"KM Walsh","year":"2023","unstructured":"Walsh KM, Price M, Neff C, Komisarow JM, Wimberly CE, Kruchko C, et al. The joint impacts of sex and race\/ethnicity on incidence of grade 1 versus grades 2\u20133 meningioma across the lifespan. Neurooncol Adv. 2023;5(Suppl 1):i5\u201312. https:\/\/doi.org\/10.1093\/noajnl\/vdad020.","journal-title":"Neurooncol Adv"},{"issue":"2","key":"1461_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","volume":"26","author":"S Blitshteyn","year":"2008","unstructured":"Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol. 2008;26(2):279\u201382. https:\/\/doi.org\/10.1200\/JCO.2007.14.2133.","journal-title":"J Clin Oncol"},{"key":"1461_CR4","doi-asserted-by":"publisher","first-page":"n37","DOI":"10.1136\/bmj.n37","volume":"372","author":"A Weill","year":"2021","unstructured":"Weill A, Nguyen P, Labidi M, Cadier B, Passeri T, Duranteau L, et al. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ. 2021;372:n37. https:\/\/doi.org\/10.1136\/bmj.n37.","journal-title":"BMJ"},{"issue":"4","key":"1461_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","volume":"105","author":"S Yano","year":"2006","unstructured":"Yano S, Kuratsu J, Kumamoto Brain Tumor Research G. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg. 2006;105(4):538\u201343. https:\/\/doi.org\/10.3171\/jns.2006.105.4.538.","journal-title":"J Neurosurg"},{"key":"1461_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yebeh.2018.09.002","volume":"88","author":"P Baumgarten","year":"2018","unstructured":"Baumgarten P, Sarlak M, Baumgarten G, Marquardt G, Seifert V, Strzelczyk A, et al. Focused review on seizures caused by meningiomas. Epilepsy Behav. 2018;88:146\u201351. https:\/\/doi.org\/10.1016\/j.yebeh.2018.09.002.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"1461_CR7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3171\/2015.4.JNS142742","volume":"124","author":"DJ Englot","year":"2016","unstructured":"Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124(6):1552\u201361. https:\/\/doi.org\/10.3171\/2015.4.JNS142742.","journal-title":"J Neurosurg"},{"issue":"2","key":"1461_CR8","first-page":"69","volume":"15","author":"AS Lieu","year":"1999","unstructured":"Lieu AS, Howng SL. Intracranial meningioma with hemorrhage. Kaohsiung J Med Sci. 1999;15(2):69\u201374.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1461_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0697-7","volume":"10","author":"D Lyndon","year":"2019","unstructured":"Lyndon D, Lansley JA, Evanson J, Krishnan AS. Dural masses: meningiomas and their mimics. Insights Imaging. 2019;10(1):11. https:\/\/doi.org\/10.1186\/s13244-019-0697-7.","journal-title":"Insights Imaging"},{"issue":"5","key":"1461_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-0034-1543959","volume":"76","author":"L Zeng","year":"2015","unstructured":"Zeng L, Liang P, Jiao J, Chen J, Lei T. Will an asymptomatic meningioma grow or not grow? A Meta-analysis. J Neurol Surg Cent Eur Neurosurg. 2015;76(5):341\u20137. https:\/\/doi.org\/10.1055\/s-0034-1543959.","journal-title":"J Neurol Surg Cent Eur Neurosurg"},{"issue":"1","key":"1461_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.crad.2006.09.009","volume":"62","author":"S O\u2019Leary","year":"2007","unstructured":"O\u2019Leary S, Adams WM, Parrish RW, Mukonoweshuro W. Atypical imaging appearances of intracranial meningiomas. Clin Radiol. 2007;62(1):10\u20137. https:\/\/doi.org\/10.1016\/j.crad.2006.09.009.","journal-title":"Clin Radiol"},{"key":"1461_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091753","author":"SJ Trybula","year":"2024","unstructured":"Trybula SJ, Youngblood MW, Karras CL, Murthy NK, Heimberger AB, Lukas RV, et al. The evolving classification of meningiomas: integration of molecular discoveries to inform patient care. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16091753.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1461_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1461_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR, Sahm F, Walsh KM, Goldbrunner R, et al. Meningioma: international consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742\u201380. https:\/\/doi.org\/10.1093\/neuonc\/noae082.","journal-title":"Neuro Oncol"},{"issue":"5","key":"1461_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/neuonc\/nos013","volume":"14","author":"H van Alkemade","year":"2012","unstructured":"van Alkemade H, de Leau M, Dieleman EM, Kardaun JW, van Os R, Vandertop WP, et al. Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol. 2012;14(5):658\u201366. https:\/\/doi.org\/10.1093\/neuonc\/nos013.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1461_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/br.2025.1934","volume":"22","author":"EK Dwianingsih","year":"2025","unstructured":"Dwianingsih EK, Krisnugraha YP, Bawono RG, Malueka RG. Molecular biomarkers in meningioma (review). Biomed Rep. 2025;22(4):56. https:\/\/doi.org\/10.3892\/br.2025.1934.","journal-title":"Biomed Rep"},{"issue":"11","key":"1461_CR17","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41591-024-03167-4","volume":"30","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Patil V, Landry AP, Gui C, Ajisebutu A, Liu J, et al. Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma. Nat Med. 2024;30(11):3173\u201383. https:\/\/doi.org\/10.1038\/s41591-024-03167-4.","journal-title":"Nat Med"},{"key":"1461_CR18","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanci","year":"2017","unstructured":"Harmanci AS, Youngblood MW, Clark VE, Coskun S, Henegariu O, Duran D, et al. Integrated genomic analyses of de Novo pathways underlying atypical meningiomas. Nat Commun. 2017;8:14433. https:\/\/doi.org\/10.1038\/ncomms14433.","journal-title":"Nat Commun"},{"issue":"19","key":"1461_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910222","volume":"22","author":"JA Pawloski","year":"2021","unstructured":"Pawloski JA, Fadel HA, Huang YW, Lee IY. Genomic biomarkers of meningioma: a focused review. Int J Mol Sci. 2021;22(19):10222. https:\/\/doi.org\/10.3390\/ijms221910222.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1461_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-021-03874-9","volume":"156","author":"SM Robert","year":"2022","unstructured":"Robert SM, Vetsa S, Nadar A, Vasandani S, Youngblood MW, Gorelick E, et al. The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications. J Neurooncol. 2022;156(2):205\u201314. https:\/\/doi.org\/10.1007\/s11060-021-03874-9.","journal-title":"J Neurooncol"},{"key":"1461_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-3-031-29750-2_2","volume":"1416","author":"CP Millward","year":"2023","unstructured":"Millward CP, Keshwara S, Islim AI, Zakaria R, Jenkinson MD. Clinical presentation and prognosis. Adv Exp Med Biol. 2023;1416:5\u201320. https:\/\/doi.org\/10.1007\/978-3-031-29750-2_2.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"1461_CR22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3171\/2019.8.JNS191266","volume":"133","author":"MW Youngblood","year":"2020","unstructured":"Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Ozduman K, et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. 2020;133(5):1345\u201354. https:\/\/doi.org\/10.3171\/2019.8.JNS191266.","journal-title":"J Neurosurg"},{"issue":"4","key":"1461_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1227\/neu.0000000000003149","volume":"96","author":"RV Patel","year":"2025","unstructured":"Patel RV, Yao S, Aguilar Murillo E, Huang RY, Bi WL. Spatial distribution of meningiomas: A magnetic resonance image atlas. Neurosurgery. 2025;96(4):769\u201378. https:\/\/doi.org\/10.1227\/neu.0000000000003149.","journal-title":"Neurosurgery"},{"issue":"2","key":"1461_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-023-04272-z","volume":"162","author":"A Dincer","year":"2023","unstructured":"Dincer A, Morales-Valero SF, Robert SM, Tabor JK, O\u2019Brien J, Yalcin K, et al. Surgical strategies for intracranial meningioma in the molecular era. J Neurooncol. 2023;162(2):253\u201365. https:\/\/doi.org\/10.1007\/s11060-023-04272-z.","journal-title":"J Neurooncol"},{"issue":"3","key":"1461_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45(3):285\u20139. https:\/\/doi.org\/10.1038\/ng.2526.","journal-title":"Nat Genet"},{"issue":"6123","key":"1461_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077\u201380. https:\/\/doi.org\/10.1126\/science.1233009.","journal-title":"Science"},{"issue":"1","key":"1461_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01040-2","volume":"8","author":"EA Williams","year":"2020","unstructured":"Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, et al. Distinct genomic subclasses of high-grade\/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun. 2020;8(1):171. https:\/\/doi.org\/10.1186\/s40478-020-01040-2.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"1461_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","volume":"23","author":"MW Youngblood","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, et al. Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. 2021;23(5):783\u201394. https:\/\/doi.org\/10.1093\/neuonc\/noaa226.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1461_CR29","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, Harmanci AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48(10):1253\u20139. https:\/\/doi.org\/10.1038\/ng.3651.","journal-title":"Nat Genet"},{"issue":"6","key":"1461_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41588-022-01077-0","volume":"54","author":"R St Pierre","year":"2022","unstructured":"St Pierre R, Collings CK, Same Guerra DD, Widmer CJ, Bolonduro O, Mashtalir N, et al. SMARCE1 deficiency generates a targetable mSWI\/SNF dependency in clear cell meningioma. Nat Genet. 2022;54(6):861\u201373. https:\/\/doi.org\/10.1038\/s41588-022-01077-0.","journal-title":"Nat Genet"},{"issue":"2","key":"1461_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00401-020-02247-2","volume":"141","author":"P Sievers","year":"2021","unstructured":"Sievers P, Sill M, Blume C, Tauziede-Espariat A, Schrimpf D, Stichel D, et al. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. Acta Neuropathol. 2021;141(2):281\u201390. https:\/\/doi.org\/10.1007\/s00401-020-02247-2.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1461_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cancergen.2015.03.005","volume":"208","author":"MS Abedalthagafi","year":"2015","unstructured":"Abedalthagafi MS, Bi WL, Merrill PH, Gibson WJ, Rose MF, Du Z, et al. ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015;208(6):345\u201350. https:\/\/doi.org\/10.1016\/j.cancergen.2015.03.005.","journal-title":"Cancer Genet"},{"issue":"11","key":"1461_CR33","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s00432-021-03586-7","volume":"147","author":"CM Gill","year":"2021","unstructured":"Gill CM, Loewenstern J, Rutland JW, Arib H, Pain M, Umphlett M, et al. SWI\/SNF chromatin remodeling complex alterations in meningioma. J Cancer Res Clin Oncol. 2021;147(11):3431\u201340. https:\/\/doi.org\/10.1007\/s00432-021-03586-7.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1461_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/now235","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol. 2017;19(4):535\u201345. https:\/\/doi.org\/10.1093\/neuonc\/now235.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1461_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol. 2014;24(2):184\u20139. https:\/\/doi.org\/10.1111\/bpa.12110.","journal-title":"Brain Pathol"},{"issue":"4","key":"1461_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","volume":"91","author":"C Mirian","year":"2020","unstructured":"Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, et al. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91(4):378\u201387. https:\/\/doi.org\/10.1136\/jnnp-2019-322257.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1461_CR37","doi-asserted-by":"publisher","unstructured":"Maier AD, Stenman A, Svahn F, Mirian C, Bartek J Jr., Juhler M, et al. TERT promoter mutations in primary and secondary WHO grade III meningioma. Brain Pathol. 2021;31(1):61\u20139. https:\/\/doi.org\/10.1111\/bpa.12892.","DOI":"10.1111\/bpa.12892"},{"key":"1461_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0023-6","volume":"2","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, et al. Erratum: Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017;2:26. https:\/\/doi.org\/10.1038\/s41525-017-0023-6.","journal-title":"NPJ Genom Med"},{"issue":"1","key":"1461_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01258-0","volume":"15","author":"EZ Erson-Omay","year":"2022","unstructured":"Erson-Omay EZ, Vetsa S, Vasandani S, Barak T, Nadar A, Marianayagam NJ, et al. Genomic profiling of sporadic multiple meningiomas. BMC Med Genomics. 2022;15(1):112. https:\/\/doi.org\/10.1186\/s12920-022-01258-0.","journal-title":"BMC Med Genomics"},{"issue":"7874","key":"1461_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, et al. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119\u201325. https:\/\/doi.org\/10.1038\/s41586-021-03850-3.","journal-title":"Nature"},{"issue":"15","key":"1461_CR41","first-page":"3226","volume":"58","author":"EP Sulman","year":"1998","unstructured":"Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, et al. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res. 1998;58(15):3226\u201330.","journal-title":"Cancer Res"},{"issue":"3 Pt 1","key":"1461_CR42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1158\/1078-0432.CCR-05-1480","volume":"12","author":"AB Espinosa","year":"2006","unstructured":"Espinosa AB, Tabernero MD, Maillo A, Sayagues JM, Ciudad J, Merino M, et al. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res. 2006;12(3 Pt 1):772\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1480.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1461_CR43","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, et al. A molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796\u2013808. https:\/\/doi.org\/10.1093\/neuonc\/noab213.","journal-title":"Neuro Oncol"},{"issue":"3","key":"1461_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, et al. CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol. 2020;140(3):409\u201313. https:\/\/doi.org\/10.1007\/s00401-020-02188-w.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1461_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00401-023-02543-7","volume":"145","author":"AB Khan","year":"2023","unstructured":"Khan AB, English CW, Chen WC, Athukuri P, Bayley J.Ct, Brandt VL, et al. Even heterozygous loss of CDKN2A\/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathol. 2023;145(4):501\u20133. https:\/\/doi.org\/10.1007\/s00401-023-02543-7.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1461_CR46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","volume":"20","author":"Y Lee","year":"2010","unstructured":"Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, et al. Genomic landscape of meningiomas. Brain Pathol. 2010;20(4):751\u201362. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00356.x.","journal-title":"Brain Pathol"},{"issue":"34","key":"1461_CR47","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, et al. Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol. 2021;39(34):3839\u201352. https:\/\/doi.org\/10.1200\/JCO.21.00784.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1461_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","volume":"27","author":"F Sahm","year":"2025","unstructured":"Sahm F, Aldape KD, Brastianos PK, Brat DJ, Dahiya S, von Deimling A, et al. CIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol. 2025;27(2):319\u201330. https:\/\/doi.org\/10.1093\/neuonc\/noae170.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1461_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1):4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644.","journal-title":"J Neurosurg"},{"issue":"2","key":"1461_CR50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3171\/2020.6.JNS201904","volume":"135","author":"TH Schwartz","year":"2021","unstructured":"Schwartz TH, McDermott MW. The simpson grade: abandon the scale but preserve the message. J Neurosurg. 2021;135(2):488\u201395. https:\/\/doi.org\/10.3171\/2020.6.JNS201904.","journal-title":"J Neurosurg"},{"issue":"6","key":"1461_CR51","doi-asserted-by":"publisher","DOI":"10.3171\/2013.9.FOCUS13319","volume":"35","author":"F Xu","year":"2013","unstructured":"Xu F, Karampelas I, Megerian CA, Selman WR, Bambakidis NC. Petroclival meningiomas: an update on surgical approaches, decision making, and treatment results. Neurosurg Focus. 2013;35(6):E11. https:\/\/doi.org\/10.3171\/2013.9.FOCUS13319.","journal-title":"Neurosurg Focus"},{"issue":"9","key":"1461_CR52","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jocn.2008.12.013","volume":"16","author":"PH Aguiar","year":"2009","unstructured":"Aguiar PH, Tahara A, Almeida AN, Simm R, Silva AN, Maldaun MV, et al. Olfactory groove meningiomas: approaches and complications. J Clin Neurosci. 2009;16(9):1168\u201373. https:\/\/doi.org\/10.1016\/j.jocn.2008.12.013.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"1461_CR53","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3171\/2023.10.JNS231432","volume":"140","author":"ED Bander","year":"2024","unstructured":"Bander ED, Pandey A, Yan J, Giantini-Larsen AM, Schwartz A, Estin J, et al. Olfactory groove meningiomas: supraorbital keyhole versus orbitofrontal, frontotemporal, or bifrontal approaches. J Neurosurg. 2024;140(6):1568\u201375. https:\/\/doi.org\/10.3171\/2023.10.JNS231432.","journal-title":"J Neurosurg"},{"issue":"4","key":"1461_CR54","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2018.1.FOCUS17753","volume":"44","author":"ST Magill","year":"2018","unstructured":"Magill ST, Morshed RA, Lucas CG, Aghi MK, Theodosopoulos PV, Berger MS, et al. Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach. Neurosurg Focus. 2018;44(4):E9. https:\/\/doi.org\/10.3171\/2018.1.FOCUS17753.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"1461_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22\u201339. https:\/\/doi.org\/10.1136\/jnnp.20.1.22.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1461_CR56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3171\/2010.3.JNS091971","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, et al. The relevance of Simpson grade I and II resection in modern neurosurgical treatment of world health organization grade I meningiomas. J Neurosurg. 2010;113(5):1029\u201335. https:\/\/doi.org\/10.3171\/2010.3.JNS091971.","journal-title":"J Neurosurg"},{"key":"1461_CR57","doi-asserted-by":"publisher","unstructured":"Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr., Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997;39(2):427\u201336. https:\/\/doi.org\/10.1016\/s0360-3016(97)00317-9.","DOI":"10.1016\/s0360-3016(97)00317-9"},{"issue":"1","key":"1461_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya S, Kawai K, Nakatomi H, Saito N. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO grade I meningiomas. J Neurosurg. 2012;117(1):121\u20138. https:\/\/doi.org\/10.3171\/2012.3.JNS111945.","journal-title":"J Neurosurg"},{"key":"1461_CR59","doi-asserted-by":"publisher","unstructured":"Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998;73(10):936\u2009\u2013\u200942. https:\/\/doi.org\/10.4065\/73.10.936","DOI":"10.4065\/73.10.936"},{"issue":"1","key":"1461_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42451-z","volume":"9","author":"JM Lemee","year":"2019","unstructured":"Lemee JM, Corniola MV, Da Broi M, Joswig H, Scheie D, Schaller K, et al. Extent of resection in meningioma: predictive factors and clinical implications. Sci Rep. 2019;9(1):5944. https:\/\/doi.org\/10.1038\/s41598-019-42451-z.","journal-title":"Sci Rep"},{"key":"1461_CR61","doi-asserted-by":"publisher","unstructured":"Morokoff AP, Zauberman J, Black PM. Surgery for convexity meningiomas. Neurosurgery. 2008;63(3):427\u2009\u2013\u200933; discussion 33\u2009\u2013\u20094. https:\/\/doi.org\/10.1227\/01.NEU.0000310692.80289.28","DOI":"10.1227\/01.NEU.0000310692.80289.28"},{"issue":"1","key":"1461_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Mirimanoff","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62(1):18\u201324. https:\/\/doi.org\/10.3171\/jns.1985.62.1.0018.","journal-title":"J Neurosurg"},{"issue":"4","key":"1461_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1042-3680(18)30091-3","volume":"11","author":"BE Pollock","year":"2000","unstructured":"Pollock BE, Stafford SL, Link MJ. Gamma knife radiosurgery for skull base meningiomas. Neurosurg Clin N Am. 2000;11(4):659\u201366.","journal-title":"Neurosurg Clin N Am"},{"issue":"S2","key":"1461_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.24875\/CIRU.22000201","volume":"90","author":"ME Akyuz","year":"2022","unstructured":"Akyuz ME, Kadioglu HH. Application of neuronavigation system in intracranial meningioma surgery: a retrospective analysis of 75 cases. Cir Cir. 2022;90(S2):92\u20137. https:\/\/doi.org\/10.24875\/CIRU.22000201.","journal-title":"Cir Cir"},{"key":"1461_CR65","doi-asserted-by":"publisher","unstructured":"Bir SC, Konar SK, Maiti TK, Thakur JD, Guthikonda B, Nanda A. Utility of Neuronavigation in Intracranial Meningioma Resection: A Single-Center Retrospective Study. World Neurosurg. 2016;90:546\u2009\u2013\u200955 e1. https:\/\/doi.org\/10.1016\/j.wneu.2015.12.101","DOI":"10.1016\/j.wneu.2015.12.101"},{"issue":"1","key":"1461_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1227\/01.NEU.0000335069.30319.1E","volume":"63","author":"PA Gardner","year":"2008","unstructured":"Gardner PA, Kassam AB, Thomas A, Snyderman CH, Carrau RL, Mintz AH, et al. Endoscopic endonasal resection of anterior cranial base meningiomas. Neurosurgery. 2008;63(1):36\u201352. https:\/\/doi.org\/10.1227\/01.NEU.0000335069.30319.1E. discussion \u2013\u20094.","journal-title":"Neurosurgery"},{"issue":"1","key":"1461_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83905-7","volume":"11","author":"P Yu","year":"2021","unstructured":"Yu P, Xu T, Wu X, Liu Z, Wang Y, Wang Y. The expanded endoscopic endonasal approach for treatment of tuberculum sellae meningiomas in a series of 40 consecutive cases. Sci Rep. 2021;11(1):4993. https:\/\/doi.org\/10.1038\/s41598-021-83905-7.","journal-title":"Sci Rep"},{"issue":"3","key":"1461_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3978\/j.issn.1000-9604.2013.06.13","volume":"25","author":"H Tang","year":"2013","unstructured":"Tang H, Sun H, Xie L, Tang Q, Gong Y, Mao Y, et al. Intraoperative ultrasound assistance in resection of intracranial meningiomas. Chin J Cancer Res. 2013;25(3):339\u201345. https:\/\/doi.org\/10.3978\/j.issn.1000-9604.2013.06.13.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"1461_CR69","doi-asserted-by":"publisher","DOI":"10.3171\/2020.10.FOCUS20797","volume":"50","author":"GM Della Pepa","year":"2021","unstructured":"Della Pepa GM, Menna G, Stifano V, Pezzullo AM, Auricchio AM, Rapisarda A, et al. Predicting meningioma consistency and brain-meningioma interface with intraoperative strain ultrasound elastography: a novel application to guide surgical strategy. Neurosurg Focus. 2021;50(1):E15. https:\/\/doi.org\/10.3171\/2020.10.FOCUS20797.","journal-title":"Neurosurg Focus"},{"issue":"9","key":"1461_CR70","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00701-009-0395-1","volume":"151","author":"O Solheim","year":"2009","unstructured":"Solheim O, Selbekk T, Lindseth F, Unsgard G. Navigated resection of giant intracranial meningiomas based on intraoperative 3D ultrasound. Acta Neurochir (Wien). 2009;151(9):1143\u201351. https:\/\/doi.org\/10.1007\/s00701-009-0395-1.","journal-title":"Acta Neurochir (Wien)"},{"issue":"Suppl 6","key":"1461_CR71","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1093\/neuonc\/noac191","volume":"24","author":"DJ McCracken","year":"2022","unstructured":"McCracken DJ, Schupper AJ, Lakomkin N, Malcolm J, Painton Bray D, Hadjipanayis CG. Turning on the light for brain tumor surgery: A 5-aminolevulinic acid story. Neuro Oncol. 2022;24(Suppl 6):S52\u201361. https:\/\/doi.org\/10.1093\/neuonc\/noac191.","journal-title":"Neuro Oncol"},{"issue":"6","key":"1461_CR72","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3171\/2015.12.JNS151513","volume":"125","author":"M Millesi","year":"2016","unstructured":"Millesi M, Kiesel B, Mischkulnig M, Martinez-Moreno M, Wohrer A, Wolfsberger S, et al. Analysis of the surgical benefits of 5-ALA-induced fluorescence in intracranial meningiomas: experience in 204 meningiomas. J Neurosurg. 2016;125(6):1408\u201319. https:\/\/doi.org\/10.3171\/2015.12.JNS151513.","journal-title":"J Neurosurg"},{"issue":"3","key":"1461_CR73","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/lsm.23294","volume":"53","author":"LI Wadiura","year":"2021","unstructured":"Wadiura LI, Millesi M, Makolli J, Wais J, Kiesel B, Mischkulnig M, et al. High diagnostic accuracy of visible 5-ALA fluorescence in meningioma surgery according to histopathological analysis of tumor bulk and peritumoral tissue. Lasers Surg Med. 2021;53(3):300\u20138. https:\/\/doi.org\/10.1002\/lsm.23294.","journal-title":"Lasers Surg Med"},{"key":"1461_CR74","doi-asserted-by":"publisher","unstructured":"Ivanidze J, Rosen K, Zgaljardic M, Lawrence JD, Forader BA, Konner M, et al. Preoperative PET\/MRI and radio-guided surgery using [Cu64]DOTATATE in meningioma: a feasibility study. Illustrative case. J Neurosurg Case Lessons. 2025;9(12). https:\/\/doi.org\/10.3171\/CASE24867.","DOI":"10.3171\/CASE24867"},{"issue":"1","key":"1461_CR75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuonc\/noac137","volume":"25","author":"CL Rogers","year":"2023","unstructured":"Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, et al. Low-risk meningioma: initial outcomes from NRG oncology\/rtog 0539. Neuro Oncol. 2023;25(1):137\u201345. https:\/\/doi.org\/10.1093\/neuonc\/noac137.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1461_CR76","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/noab132","volume":"24","author":"J Sheehan","year":"2022","unstructured":"Sheehan J, Pikis S, Islim AI, Chen CJ, Bunevicius A, Peker S, et al. An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study. Neuro Oncol. 2022;24(1):116\u201324. https:\/\/doi.org\/10.1093\/neuonc\/noab132.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1461_CR77","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","volume":"106","author":"CL Rogers","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, et al. High-risk meningioma: initial outcomes from NRG oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys. 2020;106(4):790\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1461_CR78","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","volume":"128","author":"DC Weber","year":"2018","unstructured":"Weber DC, Ares C, Villa S, Peerdeman SM, Renard L, Baumert BG, et al. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042\u201326042). Radiother Oncol. 2018;128(2):260\u20135. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.018.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1461_CR79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","volume":"129","author":"L Rogers","year":"2018","unstructured":"Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, et al. Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg. 2018;129(1):35\u201347. https:\/\/doi.org\/10.3171\/2016.11.JNS161170.","journal-title":"J Neurosurg"},{"key":"1461_CR80","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.wneu.2020.05.030","volume":"141","author":"CP Anakwenze","year":"2020","unstructured":"Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, et al. Association between facility volume and overall survival for patients with grade II meningioma after gross total resection. World Neurosurg. 2020;141:e133\u201344. https:\/\/doi.org\/10.1016\/j.wneu.2020.05.030.","journal-title":"World Neurosurg"},{"key":"1461_CR81","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003469","author":"S Gupta","year":"2025","unstructured":"Gupta S, Arora H, Chavarro VS, Nawabi NLA, Karanth R, Sadler S, et al. Evaluating adjuvant radiation therapy for grade 2 meningioma: a multi-institutional analysis. Neurosurgery. 2025. https:\/\/doi.org\/10.1227\/neu.0000000000003469.","journal-title":"Neurosurgery"},{"issue":"3","key":"1461_CR82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11060-022-03978-w","volume":"157","author":"M Marchetti","year":"2022","unstructured":"Marchetti M, Pinzi V, Iezzoni C, Morlino S, Tramacere I, De Martin E, et al. Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial. J Neurooncol. 2022;157(3):397\u2013403. https:\/\/doi.org\/10.1007\/s11060-022-03978-w.","journal-title":"J Neurooncol"},{"issue":"1","key":"1461_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijrobp.2022.08.064","volume":"115","author":"V Pinzi","year":"2023","unstructured":"Pinzi V, Marchetti M, Viola A, Tramacere I, Cane I, Iezzoni C, et al. Hypofractionated radiosurgery for large or in critical-site intracranial meningioma: results of a phase 2 prospective study. Int J Radiat Oncol Biol Phys. 2023;115(1):153\u201363. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.08.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1461_CR84","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac123","volume":"4","author":"P Kumthekar","year":"2022","unstructured":"Kumthekar P, Grimm SA, Aleman RT, Chamberlain MC, Schiff D, Wen PY, et al. A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncol Adv. 2022;4(1):vdac123. https:\/\/doi.org\/10.1093\/noajnl\/vdac123.","journal-title":"Neuro-Oncol Adv"},{"issue":"1","key":"1461_CR85","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/nou148","volume":"17","author":"TJ Kaley","year":"2015","unstructured":"Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, et al. Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro Oncol. 2015;17(1):116\u201321. https:\/\/doi.org\/10.1093\/neuonc\/nou148.","journal-title":"Neuro Oncol"},{"key":"1461_CR86","doi-asserted-by":"publisher","unstructured":"Shih KC, Chowdhary S, Rosenblatt P, Weir AB 3rd, Shepard GC, Williams JT, et al. A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma. J Neurooncol. 2016;129(2):281\u20138. https:\/\/doi.org\/10.1007\/s11060-016-2172-3.","DOI":"10.1007\/s11060-016-2172-3"},{"key":"1461_CR87","doi-asserted-by":"publisher","unstructured":"Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyriere H, et al. Everolimus and octreotide for patients with recurrent meningioma: results from the phase II cevorem trial. Clin Cancer Res. 2020;26(3):552\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2109.","DOI":"10.1158\/1078-0432.CCR-19-2109"},{"issue":"3","key":"1461_CR88","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.21.02371","volume":"41","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, et al. Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations. J Clin Oncol. 2023;41(3):618\u201328. https:\/\/doi.org\/10.1200\/JCO.21.02371.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1461_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djw320","volume":"109","author":"M Weller","year":"2017","unstructured":"Weller M, Roth P, Sahm F, Burghardt I, Schuknecht B, Rushing EJ, et al. Durable control of metastatic AKT1-mutant WHO grade 1 meningothelial meningioma by the AKT inhibitor, AZD5363. J Natl Cancer Inst. 2017;109(3):1\u20134. https:\/\/doi.org\/10.1093\/jnci\/djw320.","journal-title":"J Natl Cancer Inst"},{"key":"1461_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf009","author":"R Kotecha","year":"2025","unstructured":"Kotecha R, Akdemir EY, Kutuk T, Ilgin C, Ahluwalia MS, Bi WL, et al. Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and Meta-analysis to guide clinical trial design. Neuro Oncol. 2025. https:\/\/doi.org\/10.1093\/neuonc\/noaf009.","journal-title":"Neuro Oncol"},{"issue":"7940","key":"1461_CR91","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","volume":"612","author":"J Rustenhoven","year":"2022","unstructured":"Rustenhoven J, Kipnis J. Brain borders at the central stage of neuroimmunology. Nature. 2022;612(7940):417\u201329. https:\/\/doi.org\/10.1038\/s41586-022-05474-7.","journal-title":"Nature"},{"issue":"1","key":"1461_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29052-7","volume":"13","author":"PK Brastianos","year":"2022","unstructured":"Brastianos PK, Kim AE, Giobbie-Hurder A, Lee EQ, Wang N, Eichler AF, et al. Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022;13(1):1325. https:\/\/doi.org\/10.1038\/s41467-022-29052-7.","journal-title":"Nat Commun"},{"issue":"1","key":"1461_CR93","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/neuonc\/noab118","volume":"24","author":"WL Bi","year":"2022","unstructured":"Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, et al. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical\/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022;24(1):101\u201313. https:\/\/doi.org\/10.1093\/neuonc\/noab118.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1461_CR94","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1158\/1078-0432.CCR-23-2533","volume":"30","author":"SC Kurz","year":"2024","unstructured":"Kurz SC, Zan E, Cordova C, Troxel AB, Barbaro M, Silverman JS, et al. Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma. Clin Cancer Res. 2024;30(4):680\u20136. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-2533.","journal-title":"Clin Cancer Res"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01461-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01461-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01461-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:26:47Z","timestamp":1760423207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01461-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01461-3","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"69"}}